<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1684-1824</journal-id>
<journal-title><![CDATA[Revista Médica Electrónica]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.Med.Electrón.]]></abbrev-journal-title>
<issn>1684-1824</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas de Matanzas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1684-18242019000100117</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Supervivencia en mujeres con cáncer de mama. Hospital &#8220;José Ramón López Tabranes&#8221;. Provincia Matanzas. 2010-2015]]></article-title>
<article-title xml:lang="en"><![CDATA[Survival in women with breast cancer. Hospital &#8220;Jose Ramon Lopez Tabrane&#8221;.Province of Matanzas. 2010-2015]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García Soto]]></surname>
<given-names><![CDATA[Jesús]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Busto Hidalgo]]></surname>
<given-names><![CDATA[Jacqueline]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández Menéndez]]></surname>
<given-names><![CDATA[Miguel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Schery Guedez]]></surname>
<given-names><![CDATA[Odalys]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García Busto]]></surname>
<given-names><![CDATA[Jesús Antonio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Matanzas  ]]></institution>
<addr-line><![CDATA[ Matanzas]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Dirección Municipal de Salud de Matanzas  ]]></institution>
<addr-line><![CDATA[ Matanzas]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Universitario Clínico Quirúrgico Comandante Faustino Pérez Hernández  ]]></institution>
<addr-line><![CDATA[ Matanzas]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>02</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>02</month>
<year>2019</year>
</pub-date>
<volume>41</volume>
<numero>1</numero>
<fpage>117</fpage>
<lpage>129</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1684-18242019000100117&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1684-18242019000100117&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1684-18242019000100117&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  en el último trienio la mortalidad por cáncer mamario en el sexo femenino en Cuba disminuyó ligeramente sus tasas, sin embargo no se han realizado estudios de supervivencia por esta enfermedad en la provincia Matanzas.  Objetivo:  evaluar el comportamiento del tiempo de supervivencia global a los 5 años en esta serie y valorar la sobrevida en función de variables seleccionadas.  Materiales y métodos:  se realizó un estudio observacional descriptivo, longitudinal y retrospectivo, en el que participaron 288 mujeres diagnosticadas con cáncer de mama en la consulta de mastología del Hospital &#8220;José Ramón López Tabranes&#8221; de la provincia Matanzas, desde el 1 de Enero del 2010 hasta el 31 de Diciembre del 2015. Se utilizó el método de Kaplan Meier para determinar el tiempo de supervivencia global a los 5 años y en función de variables seleccionadas. La comparación de las diferentes curvas para las variables de exposición se realizó con la prueba de Rangos Logarítmicos (Log Rank). Se consideró estadísticamente significativo el valor del estadígrafo mayor de 1 y p &lt; 0.05.  Resultados:  la supervivencia global a los 5 años fue de un 66 %. Se registran supervivencias muy por debajo de los estándares internacionales para las pacientes en estadios III (37 %) y IV (0). La supervivencia global disminuye de manera significativa en la medida en que se incrementan el número de ganglios afectados y el tamaño del tumor al momento del diagnóstico.  Conclusiones:  la supervivencia global a los 5 años resultó inferior a la registrada en la mayoría de los estudios internacionales consultados. Se muestra una disminución marcada de la sobrevida en pacientes con estadios clínicos avanzados de la enfermedad: (III y IV).]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  in the last three years, mortality rates due to breast cancer in the female sex in Cuba slightly decreased, but studies of this disease survival have not been carried out in the province of Matanzas. Objective: to evaluate the behavior of the global survival time of this series at the 5th year and to assess survival according to chosen variables. Material and method: a retrospective, longitudinal, observational descriptive study was carried out; 288 women diagnosed with breast cancer took part on it; they were diagnosed in the mastology consultation of the hospital &#8220;Jose Ramon Lopez Tabrane&#8221;, province of Matanzas during the period January 1st 2010- December 31st 2015. The Kaplan-Meier method was used to determine the global survival time at the 5th year according to chosen variables. The comparison of the different curves for the exposition variables was made using the Log Rank test. The test value higher than 1 and p &lt; 0.05 was considered statistically significant.  Results:  global survival at the 5th year was 66 %. There are survival rates well below the international standards for the stage III (37 %) and stage IV (0) patients. Global survival significantly decreases insofar as the number of affected ganglia and the size of the tumor at the moment of the diagnosis increase.  Conclusions:  global survival at the 5th year was lower than the one recorded in most of the consulted international studies. There is a remarkable decrease of survival in patients with disease advanced clinical stages: III and IV.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[cáncer de mama]]></kwd>
<kwd lng="es"><![CDATA[supervivencia global]]></kwd>
<kwd lng="es"><![CDATA[estudio epidemiológico observacional descriptivo.]]></kwd>
<kwd lng="en"><![CDATA[breast cancer]]></kwd>
<kwd lng="en"><![CDATA[global survival]]></kwd>
<kwd lng="en"><![CDATA[retrospective]]></kwd>
<kwd lng="en"><![CDATA[longitudinal]]></kwd>
<kwd lng="en"><![CDATA[observational descriptive study.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Engel]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Stankowski-Drengler]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Stankowski]]></surname>
<given-names><![CDATA[RV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[All-cause mortality is decreased in women undergoing annual mammography before breast cancer diagnosis]]></article-title>
<source><![CDATA[AJR Am J Roentgenol]]></source>
<year>2015</year>
<numero>4</numero>
<issue>4</issue>
<page-range>898-902</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malvezzi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bertuccio]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Levi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[European cancer mortality predictions for the year 2014]]></article-title>
<source><![CDATA[Ann Oncol]]></source>
<year>2014</year>
<volume>25</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1650-6</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Allemani]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Weir]]></surname>
<given-names><![CDATA[HK]]></given-names>
</name>
<name>
<surname><![CDATA[Coleman]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[CONCORD Working Group. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2015</year>
<volume>385</volume>
<numero>9972</numero>
<issue>9972</issue>
<page-range>977-1010</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública</collab>
<source><![CDATA[Anuarios Estadísticos 2015, 2016 y 2017. Mortalidad por tumores malignos en el sexo femenino según localización y grupo de edad]]></source>
<year>2018</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[MINSAP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Angelis]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Coleman]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Capocaccia]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[EUROCARE-5 Working Group. Cancer survival in Europe 19992007 by country and age: results of EUROCARE 5 - a population-based study]]></article-title>
<source><![CDATA[Lancet Oncol]]></source>
<year>2014</year>
<volume>15</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>23-34</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Edge]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Byrd]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Compton]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
</person-group>
<source><![CDATA[AJCC Cancer Staging Manual]]></source>
<year>2010</year>
<edition>7th ed</edition>
<page-range>347-76</page-range><publisher-loc><![CDATA[New York, NY ]]></publisher-loc>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 v1. IARC CancerBase No.11]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Freitas]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Disconzi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Martins]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic factors and overall survival of breast cancer in the city of Goiania, Brazil: a population-based study]]></article-title>
<source><![CDATA[Rev Col Bras Cir]]></source>
<year>2017</year>
<volume>44</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>435-43</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carneseca]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Mauad]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Araujo]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Hospital de Câncer de Barretos Registry: an analysis of cancer survival at a single institution in Brazil over a 10-year period]]></article-title>
<source><![CDATA[BMC Res Notes]]></source>
<year>2013</year>
<volume>6</volume>
<page-range>141-51</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Unger-Saldaña]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Challenges to the early diagnosis and treatment of breast cancer in developing countries]]></article-title>
<source><![CDATA[World J Clin Oncol]]></source>
<year>2014</year>
<volume>5</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>465-77</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Freitas]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Corrêa]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[a]]></surname>
<given-names><![CDATA[et]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Contribution of the Unified Health Care System to mammography screening in Brazil, 2013]]></article-title>
<source><![CDATA[Radiol Bras]]></source>
<year>2016</year>
<volume>49</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>305-10</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Rosado]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Morales]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic Factors Associated with Survival in Women with Breast Cancer from Veracruz, México]]></article-title>
<source><![CDATA[J Cancer Sci Ther]]></source>
<year>2016</year>
<volume>8</volume>
<page-range>092-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maffuz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Labastida]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sherwell]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Supervivencia de pacientes con cáncer de mama. Análisis por factores pronóstico, clínicos y patológicos]]></article-title>
<source><![CDATA[Ginecol Obstet Mex]]></source>
<year>2016</year>
<volume>84</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>498-506</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sathwara]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bobdey]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ganesh]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Breast cancer survival studies in India: a review]]></article-title>
<source><![CDATA[Int J Res Med Sci]]></source>
<year>2016</year>
<volume>4</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>3102-8</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[YM]]></given-names>
</name>
<name>
<surname><![CDATA[Delisle]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Sagaró]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores pronósticos y supervivencia de mujeres con cáncer de mama en Santiago de Cuba]]></article-title>
<source><![CDATA[MEDISAN]]></source>
<year>2018</year>
<numero>22</numero>
<issue>22</issue>
<page-range>5</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Lemes]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Supervivencia del cáncer de mama]]></article-title>
<source><![CDATA[Archivo Médico de Camagüey]]></source>
<year>2011</year>
<volume>15</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>972-81</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baulies Caballero]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Xercavins Montosa]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Cusidó Gimferrer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Factores predictivos de respuesta a la quimioterapia neoadyuvante en cáncer de mama]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Autónoma de Barcelona]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
